NCT03333746: A reported trial by Yvonne Efebera
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03333746 |
|---|---|
| Title | Phase II Study of Lenalidomide in Combination With Nivolumab In Patients With Relapsed/Refractory Multiple Myeloma |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 21, 2018 |
| Completion date | Aug. 13, 2018 |
| Required reporting date | Aug. 13, 2019, midnight |
| Actual reporting date | Feb. 14, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |